查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1860097

麻醉和呼吸設備市場按產品類型、應用、最終用戶、技術、患者年齡層、便攜性、分銷管道、動力來源、模式和價格分佈——2025-2032年全球預測

Anesthesia & Respiratory Devices Market by Product Type, Application, End User, Technology, Patient Age Group, Mobility, Distribution Channel, Power Source, Mode, Pricing Tier - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，麻醉和呼吸設備市場規模將達到 662.3 億美元，複合年成長率為 6.41%。

主要市場統計數據
基準年 2024 402.7億美元
預計年份：2025年 428.6億美元
預測年份：2032年 662.3億美元
複合年成長率 (%) 6.41%

全面介紹影響麻醉和呼吸設備決策的營運、臨床和商業因素。

麻醉和呼吸設備市場格局受臨床優先事項、技術創新和不斷變化的醫療服務模式的共同影響，因此，經營團隊和臨床領導者需要清晰的指導才能應對。麻醉儀器、持續性正壓呼吸器（CPAP）系統、霧化器、氧氣濃縮機和人工呼吸器等設備構成了手術全期護理、加護治療、慢性病管理和家庭呼吸支持的基礎。每種設備類別內部都存在細微的配置差異。例如，麻醉儀器分為攜帶式和固定式，人工呼吸器分為有創和非侵入性兩種平台，每種平台都有不同的操作模式。這些差異至關重要，因為它們會影響醫療系統和門診護理機構的採購標準、培訓需求和生命週期管理策略。

數位轉型、分散式醫療模式和供應鏈韌性如何重新定義醫療設備組合的競爭優勢和臨床價值

麻醉和呼吸設備領域正經歷著變革性的轉變，其驅動力包括技術融合、醫療服務分散化以及患者對以患者為中心的服務日益成長的需求。在技​​術層面，傳統上以機械功能為核心的設備正在迅速整合數位感測、雲端遠端監控和嵌入式分析等技術。這種轉變增強了遠端監控能力，改善了警報管理，並支援了預測性維護，同時也對網路安全和資料管治提出了新的要求。因此，除了可靠性和臨床性能等傳統指標外，採購決策也越來越重視軟體生態系統、更新管道以及與電子健康記錄 (EHR) 的整合。

本文對2025年關稅調整如何重塑醫療設備價值鏈的籌資策略、採購重點和營運彈性進行了務實的分析。

關稅的實施將改變美國醫療保健生態系統中製造商、經銷商和買家的營運決策。關稅變化將影響籌資策略、成本結構和採購決策，而其在2025年的累積影響將取決於企業在營運和商業性的應對措施。當關稅增加投入成本或成品進口價格時，製造商通常會重新評估與供應商的關係，並可能加快本地化生產或近岸外包以降低風險。雖然這些調整可以縮短交貨時間並提高供應連續性，但它們需要資本投資和長期規劃，這可能會壓縮短期利潤率。

透過對產品類型、臨床應用、終端用戶環境和技術選擇進行深度細分，幫助確定產品開發和商業策略的優先順序。

觀點揭示了產品特性、臨床應用、終端使用者環境和技術選擇如何交織，形成差異化的需求管道。產品類型（麻醉儀器、CPAP 設備、霧化器、氧氣濃縮機和人工呼吸器）的區分是本分析的基礎，而攜帶式與固定式麻醉儀器、侵入性與非侵入性人工呼吸器架構等子類別則決定了產品的市場應用情境和臨床訓練需求。在 CPAP 平台中，自動調節系統和固定壓力系統在患者依從性和服務需求方面存在差異。同時，霧化器技術（噴射式、網式、超音波等）對霧化效果、維護和耗材的影響也各不相同。

區域差異與通用挑戰：影響美洲、歐洲、中東、非洲與亞太地區商業化與監管方式的因素

區域趨勢對設備設計、報銷通路和分銷策略有顯著影響，美洲、歐洲、中東和非洲以及亞太地區的需求各不相同。在美洲，醫療系統特別重視與電子健康記錄系統的互通性、完善的售後服務網路以及經證實的臨床和經濟價值。在這種環境下，能夠展示臨床療效並提供可擴展服務基礎設施以支援醫院和居家照護機構的供應商將更具優勢。

一項結合數位整合、服務創新和模組化產品架構的競爭性企業策略，旨在確保永續的差異化優勢。

麻醉和呼吸設備領域的主要企業正在調整研發投入、併購活動和服務創新，以確保永續的差異化優勢。市場領導正在加速將數位健康功能（例如演算法監測、遠距離診斷和無線軟體更新）整合到固定和攜帶式平台中，從而增強臨床決策支持，並透過預測性維護降低整體擁有成本。隨著企業尋求檢驗療效並展現對醫療保健系統的長期價值，與軟體供應商、雲端平台和臨床研究網路的策略合作也不斷增加。

針對產品藍圖、商業模式和供應鏈韌性，提供切實可行的建議，將策略洞察轉化為營運優勢。

產業領導者若想將洞察轉化為競爭優勢，應優先進行一系列協作行動，以解決產品、商業和營運等各個面向的問題。首先，透過與臨床醫生和居家照護護理人員共同設計產品功能，使產品開發與實際臨床工作流程相契合，確保設備的易用性、維護流程和連接性能夠滿足分散式醫療服務的需求。其次，投資建造可擴展的服務培訓基礎設施，使其能夠部署在任何場所，包括醫院、門診手術中心和家庭環境。這包括遠端支援平台、臨床人員認證項目以及標準化的維護網路，從而減少停機時間並簡化採購決策。

我們採用方法嚴謹的策略，結合關鍵相關人員對話、監管審查和情境分析，以確保其實際相關性和檢驗。

本分析的調查方法結合了嚴謹的一手研究和系統的二手分析，以確保研究結果的穩健性和實用性。一手研究活動包括與加護病房、手術室和居家醫療機構的臨床負責人、醫院和門診手術中心的採購主管以及醫療設備和分銷機構的高級產品和戰略主管進行深度訪談和結構化對話。這些對話提供了關於臨床需求、採購決策依據以及與器械實施和維護相關的營運挑戰的定性見解。

整合策略要務和實用洞見，指南您整個設備組合的投資重點、商業規劃和營運韌性。

總而言之，在數位整合、醫療服務分散化以及對供應鏈韌性的重新重視等因素的驅動下，麻醉和呼吸設備領域正經歷著顯著的變革時期。設備差異化越來越依賴臨床表現、軟體支援服務以及靈活的商業模式，以滿足醫院、門診中心和家庭等不同環境的需求。關稅調整和地緣政治趨勢正在促使企業重新評估籌資策略，並加速對區域能力的投資。同時，市場區隔洞察也凸顯了基於使用模式、便攜性性、患者年齡層和價格分佈進行產品客製化的需求。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將用於預測患者管理的人工智慧演算法整合到人工呼吸器控制系統中
  • 擴大用於居家醫療和遠端監測整合的非侵入性通氣設備
  • 開發具有封閉回路型藥物傳輸和即時病患監測的新一代麻醉儀器
  • 採用具備無線連線功能的攜帶式呼吸設備進行遠端患者管理與數據分析
  • 引入一次性麻醉管路，以降低感染風險並提高手術室週轉效率
  • 在麻醉工作站中引入先進感測器，以便早期檢測患者低氧血症和血流動力學不穩定。
  • 在加護治療環境中，高流量氧氣鼻管治療系統的需求正在迅速成長，以幫助控制呼吸窘迫。
  • 雲端基礎呼吸器資料平台在集中監控和預測性維護方面的應用日益廣泛
  • 超音波霧化器技術在慢性呼吸系統疾病治療中針對氣溶膠藥物傳遞的進展
  • 開發內建生物感測器的智慧氣管插管，用於連續監測氣道壓力和生物標記

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 按產品類型分類的麻醉和呼吸設備市場

  • 麻醉儀器
    • 可攜式的
    • 固定式
  • CPAP設備
    • 自動調節
    • 固定壓力
  • 噴霧器
    • 噴射式霧化器
    • 網狀霧化器
    • 超音波霧化器
  • 氧氣濃縮機
    • 可攜式的
    • 固定式
  • 人工呼吸器
    • 侵入性
      • 混合模式
      • 壓力控制
      • 自發呼吸模式
      • 容量控制
    • 非侵入性
      • 雙水平正壓通氣
      • 持續性氣道正壓通氣

9. 按應用分類的麻醉和呼吸設備市場

  • 救護車運輸
  • 居家醫療
  • 加護治療
    • 成人
    • 新生
    • 兒童
  • 手術室

第10章 按最終使用者分類的麻醉和呼吸設備市場

  • 門診手術中心
  • 診所
  • 居家醫療環境
  • 醫院

第11章 按技術分類的麻醉和呼吸設備市場

  • 侵入性
    • 混合模式
    • 壓力控制
    • 自發呼吸模式
    • 容量控制
  • 非侵入性
    • 雙水平正壓通氣
    • 持續性氣道正壓通氣

第12章：依病患年齡層分類的麻醉和呼吸設備市場

  • 成人
  • 新生
  • 標準

13. 按便攜性分類的麻醉和呼吸設備市場

  • 可攜式的
  • 固定式

第14章 按分銷管道分類的麻醉和呼吸設備市場

  • 直銷
  • 批發商
  • 線上

第15章 按動力來源的麻醉和呼吸設備市場

  • 電池供電
  • 電動式的
  • 手動輸入
  • 氣動

第16章 麻醉及呼吸設備市場（依模式分類）

  • 混合模式
  • 壓力控制
  • 自發呼吸模式
  • 容量控制

第17章：麻醉和呼吸設備市場（依價格分佈）

  • 低價
  • 高價
  • 標準價格

第18章：麻醉和呼吸設備市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第19章 按組別分類的麻醉和呼吸設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第20章 各國麻醉及呼吸設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第21章 競爭情勢

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Dragerwerk AG & Co. KGaA
    • Medtronic plc
    • Fisher & Paykel Healthcare Corporation Limited
    • Hamilton Medical AG
    • Smiths Group plc
    • Teleflex Incorporated
    • B. Braun Melsungen AG
    • ResMed Inc.
Product Code: MRR-8E22B6193306

The Anesthesia & Respiratory Devices Market is projected to grow by USD 66.23 billion at a CAGR of 6.41% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 40.27 billion
Estimated Year [2025] USD 42.86 billion
Forecast Year [2032] USD 66.23 billion
CAGR (%) 6.41%

A comprehensive contextual introduction to the operational, clinical, and commercial contours shaping anesthesia and respiratory device decision making

The anesthesia and respiratory device landscape is defined by converging clinical priorities, technological innovation, and shifts in care delivery that demand a clear, contextual introduction for executives and clinical leaders. Devices such as anesthesia machines, CPAP systems, nebulizers, oxygen concentrators, and ventilators serve as the backbone of perioperative, critical care, chronic disease management, and home-based respiratory support. Each device class encompasses nuanced configurations, for example anesthesia machines split into portable and stationary formats and ventilators available as invasive and noninvasive platforms with distinct operating modes. These distinctions matter because they drive procurement criteria, training needs, and lifecycle management strategies across health systems and ambulatory settings.

Beyond device taxonomy, an effective introduction must highlight how emergent pressures-aging populations, rising chronic respiratory disease prevalence, constrained acute care capacity, and an emphasis on hospital-at-home models-are reshaping demand patterns. Technology adoption is accelerating, with digital monitoring, telehealth integration, and smarter user interfaces increasingly expected across both stationary and portable products. Regulatory frameworks and reimbursement policies are evolving in tandem, emphasizing safety, interoperability, and outcomes-based performance metrics. Consequently, manufacturers and providers must align product road maps and service models with clinical pathways and supply chain realities to remain relevant.

This section establishes the foundational context for a detailed analysis by clarifying device categories, clinical applications, and the stakeholder ecosystem. It sets the stage for subsequent sections, which examine systemic shifts, tariff impacts, segmentation-based insights, regional dynamics, corporate strategies, and recommendations tailored to leaders intent on translating insight into measurable action.

How digital transformation, decentralized care models, and supply chain resilience are redefining competitive advantage and clinical value in device portfolios

The anesthesia and respiratory device sector is experiencing transformative shifts driven by technology fusion, care decentralization, and heightened expectations for patient-centric services. On the technology front, devices once defined by mechanical functionality are rapidly incorporating digital sensing, cloud-enabled telemonitoring, and embedded analytics. This transition enhances remote monitoring capabilities, improves alarm management, and supports predictive maintenance, while also creating new requirements for cybersecurity and data governance. As a result, procurement decisions increasingly weigh software ecosystems, update pathways, and integration with electronic health records alongside traditional metrics of reliability and clinical performance.

Concurrently, care delivery models are decentralizing. Hospital-at-home initiatives, expanded outpatient surgical centers, and home-based chronic respiratory management are shifting demand toward portable, battery-powered, and easy-to-operate devices. These mobility-driven preferences place a premium on intuitive user interfaces, maintenance simplicity, and logistics solutions that support device rotation and servicing across dispersed settings. Moreover, clinicians and health system leaders are placing greater emphasis on patient experience and adherence, particularly for long-term therapies like CPAP and oxygen concentrators, which prompts product developers to invest in comfort features and behavioral engagement tools.

Supply chain resilience has emerged as a strategic priority following recent global disruptions, accelerating efforts to diversify suppliers, regionalize manufacturing, and build redundancy in critical components. Regulatory regimes are adapting to novel device modalities and software-as-medical-device constructs, prompting manufacturers to adopt more rigorous post-market surveillance and evidence-generation plans. Taken together, these forces are reshaping competitive advantages across the ecosystem, privileging organizations that can deliver integrated clinical outcomes, service excellence, and flexible deployment models.

Practical analysis of how 2025 tariff adjustments are reshaping sourcing strategies, procurement priorities, and operational agility across the device value chain

The imposition of tariffs alters the operating calculus for manufacturers, distributors, and purchasers within the United States healthcare ecosystem. Tariff changes influence procurement strategies, cost structures, and sourcing decisions, and their cumulative effect in 2025 will be shaped by how companies respond operationally and commercially. When tariffs increase input costs or finished-goods import prices, manufacturers commonly reassess supplier relationships and may accelerate regional manufacturing or nearshoring to mitigate exposure. These adjustments can reduce delivery lead times and improve supply continuity, but they also require capital investment and longer-run planning that can compress short-term margins.

For health systems and other end users, tariff-driven price pressures may translate into more rigorous procurement evaluations and heightened interest in total cost of ownership analyses that include maintenance, consumables, and device uptime. Procurement teams may prioritize devices with lower lifecycle service costs or favor vendors that offer bundled maintenance and consumable agreements designed to stabilize expenses. In parallel, distributors and online channels may play a larger role as intermediaries that absorb some operational variability by leveraging scale and flexible inventory strategies.

Regulatory compliance and documentation burdens also shift along with tariff changes, as cross-border movement of components often necessitates additional customs reporting and classification reviews. Smaller OEMs and start-ups can be disproportionately affected due to limited resources to reconfigure supply chains quickly. Conversely, larger companies with diversified manufacturing footprints may gain competitive advantage by reallocating production and preserving pricing stability. Across the value chain, strategic responses center on operational agility, contract renegotiation, and targeted investment in regional capacity to limit the operational and financial friction introduced by tariff interventions.

Deep segmentation insights linking product types, clinical applications, end-user settings, and technology choices to prioritize product development and commercial strategies

A segmentation-informed perspective reveals how product attributes, clinical applications, end-user environments, and technology choices intersect to create differentiated demand pathways. Product type distinctions-spanning anesthesia machines, CPAP devices, nebulizers, oxygen concentrators, and ventilators-are foundational to this analysis, with subcategories such as portable versus stationary anesthesia machines and invasive versus noninvasive ventilator architectures dictating deployment scenarios and clinical training needs. Within CPAP platforms, the split between auto-adjusting and fixed-pressure systems creates divergent patient adherence profiles and service requirements, while nebulizer technologies such as jet, mesh, and ultrasonic variants carry distinct efficacy, maintenance, and consumable implications.

Application-based segmentation further refines insight by connecting device capabilities to clinical contexts; emergency and transport solutions demand ruggedized, rapidly deployable systems that prioritize battery longevity and ease of use, whereas intensive care units require ventilators and anesthesia systems with advanced modes tailored to adult, neonatal, and pediatric physiology. End-user segmentation across ambulatory surgical centers, clinics, home care settings, and hospitals highlights how procurement cycles, service contracts, and training investments vary by institutional maturity and operational complexity. Technology segmentation reiterates the invasive and noninvasive divide, underlining how mode-specific performance characteristics, including hybrid mode, pressure control, spontaneous mode, and volume control, influence clinician preference and regulatory pathways.

Patient age group classifications-adult, neonatal, and standard-intersect with mobility and power source segments, shaping product design priorities such as compactness, battery options, and ergonomics for caregivers. Distribution channel choices between direct sales, distributors, and online platforms compel manufacturers to align commercial models with buyer behavior and after-sales service expectations. Finally, pricing tier segmentation into economy, premium, and standard offerings drives positioning strategies, with premium devices emphasizing integrated analytics and service bundles while economy models focus on cost-effective reliability for resource-constrained settings. Together, these segmentation lenses enable more granular product prioritization, go-to-market planning, and lifecycle support strategies.

Regional divergence and converging imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape commercialization and regulatory approaches

Regional dynamics exert a powerful influence on device design, reimbursement pathways, and distribution strategies, with distinct imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, health systems place substantial emphasis on interoperability with electronic health record systems, robust aftermarket service networks, and evidence of clinical and economic value. This environment favors vendors that can demonstrate clinical outcomes and provide scalable service infrastructures to support hospitals and home care providers alike.

Europe, the Middle East & Africa present a heterogeneous landscape in which regulatory alignment with centralized European frameworks coexists alongside variable procurement models and health financing mechanisms across countries. Manufacturers operating in this geography must navigate harmonized device standards while adapting to local market access challenges and diverse clinical practice patterns. The need for adaptable service models and flexible pricing strategies is particularly acute in regions with mixed public and private provision.

Asia-Pacific is characterized by rapid adoption of portable and cost-efficient technologies, driven by expanding access to care, growing chronic disease prevalence, and investments in primary and community health capacity. Manufacturers targeting this region often prioritize scalable production, localized service partnerships, and product variants optimized for high-volume, resource-constrained settings. Across all regions, collaborations between global OEMs and regional distributors or contract manufacturers remain a central strategy to balance quality control, cost management, and market responsiveness.

Competitive corporate strategies that combine digital integration, service innovation, and modular product architectures to secure sustainable differentiation

Leading companies in the anesthesia and respiratory device space are aligning R&D investment, M&A activity, and service innovation to secure durable differentiation. Market leaders are accelerating integration of digital health features-algorithmic monitoring, remote diagnostics, and over-the-air software updates-into both stationary and portable platforms to enhance clinical decision support and reduce total cost of ownership through predictive maintenance. Strategic partnerships with software vendors, cloud platforms, and clinical research networks are becoming more common as firms seek to validate outcomes and demonstrate longitudinal value to health systems.

Corporate strategies increasingly emphasize service-led revenue streams, including managed service agreements, consumables contracts, and training-as-a-service offerings that deepen customer relationships and create recurring revenue. In parallel, product road maps show greater emphasis on modular architectures that allow OEMs to offer tiered configurations across economy, standard, and premium pricing tiers without regenerating entirely new hardware platforms.

Smaller innovators and niche players play a complementary role by advancing specific technologies such as low-cost mesh nebulizers, compact bilevel positive airway pressure systems, or neonatal-focused ventilator modes. These companies often attract partnerships with larger manufacturers seeking to broaden portfolios or accelerate time-to-market for new features. Across the competitive landscape, success favors firms that combine clinical validation, robust aftermarket support, and flexible commercial models that map to both institutional procurement cycles and patient-centric care pathways.

Actionable recommendations for product road maps, commercial models, and supply chain resilience to translate strategic insight into operational advantage

Industry leaders seeking to convert insight into advantage should prioritize a set of coordinated actions that address product, commercial, and operational dimensions. First, align product development with real-world clinical workflows by co-designing features with frontline clinicians and home-care providers, ensuring that device usability, maintenance protocols, and connectivity meet the demands of distributed care delivery. Second, invest in scalable service and training infrastructures that can be deployed across hospitals, ambulatory surgical centers, and home settings; this includes remote support platforms, certification programs for clinical staff, and standardized maintenance networks that reduce downtime and simplify procurement decisions.

Third, build supply chain flexibility by diversifying component sourcing, evaluating nearshoring opportunities, and developing contingency inventories for critical parts to reduce exposure to tariff and geopolitical shocks. Fourth, adopt commercial models that reflect buyer preferences across distribution channels, including direct sales for large health systems, distributor partnerships for regional reach, and online offerings for smaller purchasers and home users. Fifth, accelerate evidence generation through post-market surveillance, user experience studies, and real-world outcomes research to support regulatory filings, payer discussions, and purchasing committees.

Finally, prioritize cybersecurity and data governance early in product design to address emerging compliance requirements and protect patient data across connected devices. Collectively, these actions help firms reduce time-to-value for customers, build defensible revenue streams, and maintain operational resilience in a rapidly evolving clinical and regulatory environment.

A methodologically rigorous approach combining primary stakeholder engagement, regulatory review, and scenario analysis to ensure practical relevance and validation

The research methodology underpinning this analysis combines rigorous primary engagement with structured secondary analysis to ensure robustness and practical relevance. Primary research activities included in-depth interviews and structured conversations with clinical leaders across intensive care, operating room, and home care settings, procurement executives from hospitals and ambulatory surgical centers, and senior product and strategy leaders within device and distribution organizations. These interactions provided qualitative insight into clinical requirements, purchasing rationales, and the operational challenges associated with device deployment and maintenance.

Secondary research entailed systematic review of regulatory guidance documents, clinical practice guidelines, and peer-reviewed clinical literature that inform device design and modes of operation. Market intelligence was triangulated through a thorough assessment of product literature, technical specifications, and service offerings to validate claims and identify feature differentials across portfolios. Where appropriate, real-world device usage patterns and case studies were examined to understand performance under typical clinical and home-care conditions.

Analytical techniques included scenario planning to assess the operational impacts of tariff changes and supply chain disruptions, segmentation analysis to map product features to clinical contexts, and comparative benchmarking to evaluate aftermarket service models. Throughout the process, findings were validated through iterative stakeholder feedback to ensure accuracy, practical relevance, and applicability to strategic decision-making.

Synthesis of strategic imperatives and practical takeaways to guide investment priorities, commercial planning, and operational resilience in device portfolios

In summary, the anesthesia and respiratory device sector is undergoing a period of meaningful transformation driven by digital integration, decentralization of care, and a renewed focus on supply chain resilience. Device differentiation increasingly rests on the combination of clinical performance, software-enabled services, and flexible commercial models that serve hospitals, ambulatory centers, and home settings. Tariff changes and geopolitical dynamics are prompting re-evaluation of sourcing strategies and accelerating investments in regional capacity, while segmentation insights clarify the need for tailored product variants across modes, mobility profiles, patient age groups, and pricing tiers.

For stakeholders across the value chain-from manufacturers and distributors to clinical purchasing teams and health system strategists-the imperative is to adopt a holistic approach that integrates product development, service innovation, and operational agility. By doing so, organizations can better align offerings with clinician workflows, patient expectations, and evolving regulatory requirements. The conclusions drawn here provide a strategic framework for prioritizing investment, refining go-to-market approaches, and building resilient operations that are responsive to both near-term disruptions and longer-term shifts in how respiratory and anesthesia care is delivered.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms into ventilator control systems for predictive patient management
  • 5.2. Expansion of non-invasive ventilation devices for home care and telemonitoring integration
  • 5.3. Development of next-generation anesthesia machines with closed-loop drug delivery and real-time patient monitoring
  • 5.4. Adoption of portable respiratory devices with wireless connectivity for remote patient management and data analytics
  • 5.5. Emergence of single-use anesthesia circuits to reduce infection risk and improve operating room turnover efficiency
  • 5.6. Implementation of advanced sensors in anesthesia workstations for early detection of patient hypoxia and hemodynamic instability
  • 5.7. Surge in demand for high-flow nasal cannula therapy systems in critical care settings to support respiratory distress management
  • 5.8. Rising incorporation of cloud-based ventilation data platforms for centralized monitoring and predictive maintenance
  • 5.9. Advancements in ultrasonic nebulizer technology for targeted aerosol drug delivery in chronic respiratory disease management
  • 5.10. Development of smart endotracheal tubes with embedded biosensors for continuous monitoring of airway pressures and biomarkers

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anesthesia & Respiratory Devices Market, by Product Type

  • 8.1. Anesthesia Machines
    • 8.1.1. Portable
    • 8.1.2. Stationary
  • 8.2. Cpap Devices
    • 8.2.1. Auto Adjusting
    • 8.2.2. Fixed Pressure
  • 8.3. Nebulizers
    • 8.3.1. Jet Nebulizer
    • 8.3.2. Mesh Nebulizer
    • 8.3.3. Ultrasonic Nebulizer
  • 8.4. Oxygen Concentrators
    • 8.4.1. Portable
    • 8.4.2. Stationary
  • 8.5. Ventilators
    • 8.5.1. Invasive
      • 8.5.1.1. Hybrid Mode
      • 8.5.1.2. Pressure Control
      • 8.5.1.3. Spontaneous Mode
      • 8.5.1.4. Volume Control
    • 8.5.2. Noninvasive
      • 8.5.2.1. Bilevel Positive Airway Pressure
      • 8.5.2.2. Continuous Positive Airway Pressure

9. Anesthesia & Respiratory Devices Market, by Application

  • 9.1. Emergency And Transport
  • 9.2. Home Care
  • 9.3. Intensive Care
    • 9.3.1. Adult
    • 9.3.2. Neonatal
    • 9.3.3. Pediatric
  • 9.4. Operating Room

10. Anesthesia & Respiratory Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Home Care Settings
  • 10.4. Hospitals

11. Anesthesia & Respiratory Devices Market, by Technology

  • 11.1. Invasive
    • 11.1.1. Hybrid Mode
    • 11.1.2. Pressure Control
    • 11.1.3. Spontaneous Mode
    • 11.1.4. Volume Control
  • 11.2. Noninvasive
    • 11.2.1. Bilevel Positive Airway Pressure
    • 11.2.2. Continuous Positive Airway Pressure

12. Anesthesia & Respiratory Devices Market, by Patient Age Group

  • 12.1. Adult
  • 12.2. Neonatal
  • 12.3. Standard

13. Anesthesia & Respiratory Devices Market, by Mobility

  • 13.1. Portable
  • 13.2. Stationary

14. Anesthesia & Respiratory Devices Market, by Distribution Channel

  • 14.1. Direct
  • 14.2. Distributor
  • 14.3. Online

15. Anesthesia & Respiratory Devices Market, by Power Source

  • 15.1. Battery
  • 15.2. Electric
  • 15.3. Manual
  • 15.4. Pneumatic

16. Anesthesia & Respiratory Devices Market, by Mode

  • 16.1. Hybrid Mode
  • 16.2. Pressure Control
  • 16.3. Spontaneous Mode
  • 16.4. Volume Control

17. Anesthesia & Respiratory Devices Market, by Pricing Tier

  • 17.1. Economy
  • 17.2. Premium
  • 17.3. Standard

18. Anesthesia & Respiratory Devices Market, by Region

  • 18.1. Americas
    • 18.1.1. North America
    • 18.1.2. Latin America
  • 18.2. Europe, Middle East & Africa
    • 18.2.1. Europe
    • 18.2.2. Middle East
    • 18.2.3. Africa
  • 18.3. Asia-Pacific

19. Anesthesia & Respiratory Devices Market, by Group

  • 19.1. ASEAN
  • 19.2. GCC
  • 19.3. European Union
  • 19.4. BRICS
  • 19.5. G7
  • 19.6. NATO

20. Anesthesia & Respiratory Devices Market, by Country

  • 20.1. United States
  • 20.2. Canada
  • 20.3. Mexico
  • 20.4. Brazil
  • 20.5. United Kingdom
  • 20.6. Germany
  • 20.7. France
  • 20.8. Russia
  • 20.9. Italy
  • 20.10. Spain
  • 20.11. China
  • 20.12. India
  • 20.13. Japan
  • 20.14. Australia
  • 20.15. South Korea

21. Competitive Landscape

  • 21.1. Market Share Analysis, 2024
  • 21.2. FPNV Positioning Matrix, 2024
  • 21.3. Competitive Analysis
    • 21.3.1. GE HealthCare Technologies Inc.
    • 21.3.2. Koninklijke Philips N.V.
    • 21.3.3. Dragerwerk AG & Co. KGaA
    • 21.3.4. Medtronic plc
    • 21.3.5. Fisher & Paykel Healthcare Corporation Limited
    • 21.3.6. Hamilton Medical AG
    • 21.3.7. Smiths Group plc
    • 21.3.8. Teleflex Incorporated
    • 21.3.9. B. Braun Melsungen AG
    • 21.3.10. ResMed Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2024 VS 2032 (%)
  • FIGURE 17. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2032 (%)
  • FIGURE 19. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2024 VS 2032 (%)
  • FIGURE 21. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AMERICAS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 34. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 35. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 36. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 37. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 38. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 39. ANESTHESIA & RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 40. ANESTHESIA & RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANESTHESIA & RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ANESTHESIA & RESPIRATORY DEV